Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EC.1ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
EC.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
EC.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
EC.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
EC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EC.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EC.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EC.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
EC.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
EC.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EC.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
EC.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EC.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EC.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
EC.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
EC.1ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
BA.5.2.52ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
BA.5.2.52ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
BA.5.2.52ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.52ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-2052.38South Korea
BA.5.2.52ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-301.668South Korea
BA.5.2.52ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
BA.5.2.52ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
BA.5.2.52SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.52SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.2.52SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BA.5.2.52EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.52EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.52ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.52ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.52NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-18184Thailand
BA.5.2.52NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
BA.5.2.52NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.52NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
BA.5.2.52NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.52NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.52NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.5.2.52NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.5.2.52ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
XMORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
XMORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
XMORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XMORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
XMORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XMORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
XMORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
XMSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBQORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
XBQORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used